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Abstract
Objectives:  To  evaluate  total  serum  calcium  (TC)  and  albumin-corrected  calcium  (ACC)  as
prognostic  severity  factors  in  acute  pancreatitis  (AP).
Methods:  Ninety-six  patients  were  included  in  the  study.  They  were  diagnosed  with  AP  and
admitted to  the  Hospital  Regional  de  Veracruz  within  the  time  frame  of  January  2010  to  Decem-
ber 2012.  AP  severity  was  determined  through  the  updated  Atlanta  Classiﬁcation  (2013).  TC  and
ACC values  were  measured  in  the  ﬁrst  24  hours  of  admittance  and  the  percentages  of  sensitivity
(S), speciﬁcity  (Sp),  positive  predictive  value  (PPV),  negative  predictive  value  (NPV),  positive
likelihood  ratio  (LR  +  ),  and  negative  likelihood  ratio  (LR-)  were  calculated  through  ROC  curves
and contingency  tables.
Results:  In  accordance  with  the  updated  Atlanta  Classiﬁcation,  70  patients  presented  with
mild AP,  17  with  moderately  severe  AP,  and  9  with  severe  AP.  Of  the  patient  total,  61.5%
were women,  and  69.8%  presented  with  biliary  etiology.  The  maximum  TC  cut-off  point  was
7.5 mg/dL,  with  values  of  S,  67%;  Sp,  82%;  PPV,  27%,  and  NPV,  96%.  The  maximum  ACC  cut-off
point was  7.5  mg/dL,  with  values  of  S,  67%;  Sp,  90%;  PPV,  40%;  NPV,  96%.  Both  had  values  similar
to those  of  the  Ranson  and  APACHE  II  prognostic  scales.
Conclusions:  TC  and  ACC,  measured  within  the  ﬁrst  24  hours,  are  useful  severity  predictors  in
acute pancreatitis,  with  sensitivity  and  predictive  values  comparable  or  superior  to  those  of
the conventional  prognostic  scales.
© 2013  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
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Resumen
Objetivo:  Evaluar  el  calcio  sérico  total  (CT)  y  el  calcio  corregido  por  albúmina  (CCA)  como
factores  pronósticos  de  severidad  en  pancreatitis  aguda  (PA).
Métodos:  Se  incluyó  a  96  pacientes  con  diagnóstico  de  PA  ingresados  de  enero  del  2010  a  diciem-
bre del  2012  en  el  Hospital  Regional  de  Veracruz.  La  severidad  de  la  PA  se  determinó  utilizando
la Clasiﬁcación  de  Atlanta  actualizada  (2013).  Se  recolectaron  los  valores  de  CT  y  CCA  en  las
primeras 24  h  a  partir  del  ingreso  y  se  calcularon  los  porcentajes  de  sensibilidad  (S),  especiﬁ-
cidad (E),  valores  predictivos  positivo  y  negativo  (VPP  y  VPN)  y  razones  de  verosimilitud  (RVP  y
PVN) por  medio  de  curvas  ROC  y  tablas  de  contingencia.
Resultados:  De  acuerdo  con  los  criterios  de  la  Clasiﬁcación  de  Atlanta  actualizada,  70  pacientes
presentaron  PA  leve,  17  PA  moderadamente  grave  y  9  PA  grave.  Del  total  de  pacientes,  61.5%
fueron mujeres,  y  el  69.8%  presentó  etiología  biliar.  El  CT  tuvo  un  punto  de  corte  óptimo  de
7.5 mg/dl,  con  valores  de  S,  67%;  E,  82%;  VPP,  27%  y  VPN,  96%.  El  CCA  tuvo  un  punto  de  corte
óptimo de  7.5  mg/dl,  con  valores  de  S  67%;  E,  90%;  VPP,  40%;  VPN,  96%.  Ambos  obtuvieron
valores similares  a  los  de  las  escalas  pronósticas  de  Ranson  y  APACHE  II.
Conclusiones:  El  CT  y  CCA  tomados  en  las  primeras  24  h  son  útiles  como  predictores  de  severidad
en pancreatitis  aguda,  con  valores  de  S  y  predictivos  comparables  o  superiores  a  los  de  las
escalas pronósticas  tradicionales.
©  2013  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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cute  pancreatitis  (AP)  is  an  acute  inﬂammatory  process  of
he  pancreas  that  affects  other  regional  tissues  and  more
istant  organ  systems  in  a  variety  of  ways.1 Histologically  it
s  characterized  by  acinar  cell  necrosis  and  the  presence  of
nﬂammatory  inﬁltrate  in  the  parenchyma.2 Every  year  there
re  between  5  and  80  new  cases  per  100,000  inhabitants.3
n  the  last  decade,  in  the  U.S.  and  in  Europe,  a  decrease  in
he  number  of  fatal  cases  and  a  noticeable  increase  in  hos-
italizations  due  to  AP,  speciﬁcally  those  related  to  biliary
tiology,  have  been  reported.4
The  general  consensus  is  that  2  of  the  following  3  char-
cteristics  are  necessary  for  making  AP  diagnosis:  intense
pigastric  pain,  a  serum  amylase  or  lipase  concentration
 times  higher  than  the  normal  limit,  and  characteristic  AP
ndings  through  computed  tomography.5 The  clinical  course
aries  signiﬁcantly  from  person  to  person.  Although  it  is
enerally  self-limited,  through  the  AP  classiﬁcation  crite-
ia  from  1992,  it  has  been  determined  that  on  average,  20%
f  the  patients  present  with  severe  disease,  with  a  mortality
ate  of  50%.6,7 The  use  of  prognostic  scales  enables  severe
ases  to  be  detected  and  opportune  and  adequate  manage-
ent  to  be  established.8 The  most  widely  used  are  the  Ran-
on  and  APACHE-II  scores5,9,10 and  the  Balthazar  computed
omography  severity  index. 11 Biochemical  markers  have
lso  turned  out  to  be  useful  predictors.  Examples  of  some  of
hem  are:  C-reactive  protein,  procalcitonin,  interleukin-6,
hioredoxin-1,  and  polymorphonuclear  elastase. 6,12--14
Hypocalcemia  has  been  associated  with  AP  severity  but
ts  etiopathogenesis  has  been  a  subject  of  debate  for
ecades.  Centuries-old  literature  reported  that  in  1890
angerhans  observed  calcium  deposits  in  areas  of  fat  necro-
is.  Later  Edmondson,  in  1944,  postulated  that  hypocalcemia
A
M
s
mas  due  to  the  formation  of  calcium  soaps. 15 In  1975,
ondon  et  al.  reported  on  the  increase  in  parathyroid  hor-
one  in  patients  with  hypocalcemia  and  normocalcemia
nd  suggested  that  parathyroid  hormone  depletion  was  the
ain  induction  factor  of  persistent  hypocalcemia  in  AP.16
n  1976,  Imrie  et  al.  associated  hypocalcemia  with  hypoal-
uminemia  and  proposed  that  total  serum  calcium  (TC)
hould  be  corrected  in  accordance  with  albumin  concen-
ration  before  taking  therapeutic  measures.17 AP  studies
sing  animal  experimental  models  have  shown  that  ion-
zed  calcium  and  total  calcium  concentrations  decrease  6
o  18  h  after  pancreatitis  induction,  in  addition  to  the  fact
hat  the  onset  of  hypocalcemia  is  associated  with  the  accu-
ulation  of  calcium  in  the  soft  tissues.18,19 More  recently,
he  role  of  the  parathyroid  hormone  has  been  taken  up
gain  in  relation  to  the  pathogenesis  of  hypocalcemia  in
P,  and  it  has  been  postulated  that  the  condition  is  the
esult  of  an  inadequate  parathyroid  response;  it  is  even
robable  that,  just  as  in  other  critical  diseases,  its  origin
s  multifactorial.20--23Given  its  importance,  TC  has  a  place
n  some  of  the  AP  prognostic  severity  scales. 10,24 Indi-
idually,  it  has  been  evaluated  as  a  mortality  prognostic
actor 25,26 and  it  has  also  been  evaluated  as  a predictor
f  severe  AP  with  infection.27 Albumin-corrected  calcium
ACC)  has  also  been  associated  with  severity,28,29 but  we
ave  not  found  studies  that  evaluate  it as  a prognostic
everity  factor  within  the  ﬁrst  24  h  of  the  patient’s  hospital
dmittance.
Due  to  the  availability  of  TC  determination  tests  in  sec-
ndary  care  health  centers  in  Mexico,  we  feel  that  TC  and
CC  can  be  used  as  easily  accessible  AP  severity  tests  in  the
exican  health  system.  Therefore  the  aim  of  the  present
tudy  was  to  evaluate  TC  and  ACC  as  prognostic  severity
arkers  in  AP.
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Methods
This  study  was  conducted  on  patients  that  were  admitted
to  the  Hospital  Regional  de  Veracruz  within  the  time  frame
of  January  2010  and  December  2012  that  were  diagnosed
with  ﬁrst-time  AP  and  who  were  admitted  within  72  h  of  the
onset  of  epigastric  pain.  All  patients  under  18  years  of  age,
patients  whose  management  was  not  completed  at  our  hos-
pital,  and  those  whose  medical  records  were  incomplete
were  excluded  from  the  study.  The  following  clinical  and
demographic  data  were  collected  from  the  medical  records:
sex,  age,  previous  history  of  pancreatitis,  pathologic  history,
TC  taken  24  h  after  admission,  serum  albumin,  amylase  and
lipase,  Ranson  and  APACHE-II  scores,  and  imaging  and  com-
puted  tomography  data  in  the  cases  of  patients  with  severe
or  moderately  severe  AP.
AP  diagnosis  was  made  based  on  the  American  College  of
Gastroenterology  recommendations,  and  the  presence  of  2
of  the  3  following  characteristics  was  established:  intense
epigastric  pain,  serum  amylase  or  lipase  ≥  3  times  above
the  normal  limit,  and  characteristic  AP  ﬁndings  in  the  CT
images.5,30 The  patients  were  classiﬁed  into  3  groups  in
accordance  with  the  revised  Atlanta  Classiﬁcation  (pub-
lished  in  2013):  severe  AP  (associated  with  persistent  organ
failure  longer  than  48  h  with  or  without  local  or  systemic
complications),  moderately  severe  AP  (that  presents  with
local  or  systemic  complications,  with  no  persistent  organ
failure),  and  mild  AP  (with  no  organ  failure  or  local  or  sys-
temic  complications).30
In  order  to  evaluate  TC  and  ACC  as  prognostic  factors
of  severity,  the  lowest  TC  values  were  collected  within  the
ﬁrst  24  h  of  hospital  admittance.  These  values  were  then
corrected  according  to  the  serum  albumin  level  (see  for-
mula),  thus  obtaining  the  ACC. 31ACC  =  TC  +  (0.8  *  [4  --  serum
albumin  concentration])
Data  analysis
Data  were  analyzed  through  descriptive  statistics  to  deter-
mine  the  general  population  characteristics.  The  one-way
ANOVA,  the  Kruskal-Wallis  test,  and  the  chi-square  test  were
employed  to  establish  the  statistical  signiﬁcance  of  the  dif-
ferences  between  groups,  according  to  the  characteristics
of  the  analyzed  variables.  Statistical  signiﬁcance  was  deter-
mined  with  a  p  <  0.05.  ROC  curves  were  used  in  order  to
establish  the  possible  cut-off  values  for  TC  and  ACC.  The
maximum  cut-off  value  was  utilized  to  calculate  the  sensi-
tivity  (S),  speciﬁcity  (Sp),  positive  predictive  value  (PPV),
negative  predictive  value  (NPV),  positive  likelihood  ratio
(PLR),  and  negative  likelihood  ratio  (NLR)  of  each  criterion
by  means  of  contingency  tables.  For  comparison  purposes,
the  same  values  were  calculated  for  the  Ranson  prognostic
tests  48  h  after  admission  and  the  APACHE-II  prognostic  test
upon  hospital  admission.  Odds  ratio  (OR)  was  employed  to
evaluate  the  cut-off  values  as  relative  risks  for  developing
severe  pancreatitis.  All  the  statistical  analyses  were  done
using  the  IBMTM SPSSTM 19  program.Ethical  aspects
The  study  was  approved  by  the  Research  and  Ethics
Committee  of  the  Hospital  Regional  de  Veracruz  in  strict
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dherence  to  the  2008  revised  Declaration  of  Helsinki  and
he  General  Health  Law  in  matters  of  Health  Research,
econd  Title,  Chapter  I,  Article  17,  Section  I,  negligible  risk
esearch.  There  was  no  harm  to  patients,  given  that  the
ata  were  collected  retrospectively  from  medical  records.
ll  the  necessary  precautions  were  taken  to  safeguard
atient  data  conﬁdentiality,  allowing  the  medical  records
nd  databases  to  be  used  only  by  the  researchers,  utilizing
 consecutive  code  to  identify  them  that  had  no  relation  to
he  corresponding  medical  record  number  or  to  the  initials
f  the  patients’  names.
esults
ithin  the  study  time  frame,  the  medical  records  of
6  patients  met  the  inclusion  criteria,  70  (72.9%)  of  which
resented  with  mild  AP,  17  (17.9%)  with  moderately  severe
P,  and  9  (9.4%)  with  severe  AP.  No  signiﬁcant  differ-
nce  was  observed  in  the  mean  age  (mild  AP  39.45  ±
4.51  years,  moderately  severe  AP  41.58  ±  13.28  years,
evere  AP  41.78  ±  9.01  years;  ANOVA,  p  =  0.759)  or  in  sex
istribution  (chi-square,  p  = 0.170)  among  the  3  groups.  Of
he  patient  total,  61.5%  were  women  and  38.5%  were  men.
iliary  etiology  was  the  most  frequent,  representing  69.8%
f  the  cases.  Of  the  patient  total,  only  3  (3.1%)  died,  2  of
hich  had  severe  AP  (both  died  in  the  early  phase)  and  one
ad  moderately  severe  AP  (and  died  in  the  late  phase).  The
est  of  the  general  patient  characteristics  are  detailed  in
able  1  and  their  complications  in  Table  2.
The  one-way  ANOVA  test  with  the  Tukey-B  post  hoc  test
howed  signiﬁcant  differences  in  the  TC  concentration  of  the
atients  in  the  3  groups  (p  =  0.000;  see  Table  3).  The  mean
CC  was  also  signiﬁcantly  lower  in  the  patients  presenting
ith  severe  and  moderately  severe  AP,  compared  with  the
ild  AP  patients  (p  =  0.000;  Table  3).  The  Ranson  (p  =  0.000)
nd  APACHE-II  (p  =  0.000)  scores  were  signiﬁcantly  higher  in
he  patients  with  severe  and  moderately  severe  AP  than
n  those  with  mild  AP.  Because  the  scores  of  these  2  scales
ere  not  normally  distributed,  they  were  analyzed  using  the
ruskal-Wallis  test  and  the  group  comparisons  were  made
sing  the  Mann-Whitney  U  test  (Table  3).
erum  calcium  and  corrected  calcium  as  severe
ancreatitis predictors
he  results  of  the  analysis  with  ROC  curves  showed  that  the
aximum  cut-off  value  (with  a  better  compromise  between
 and  Sp,  see  ﬁgure  1) for  both  TC  and  ACC  was  7.5  mg/dl.
he  same  cut-off  values  for  S  and  Sp  were  obtained  through
he  contingency  table  analysis,  conﬁrming  the  ROC  curve
esults.  The  results  of  the  S,  Sp,  predictive  values,  and  like-
ihood  ratios  for  TC  were:  S,  67%;  Sp,  82%;  PPV,  27%;  NPV,
6%;  LR+,  3.62;  and  LR-,  0.41,  and  the  values  found  for  ACC
ere:  S,  67%;  Sp,  90%;  PPV,  40%;  NPV,  96%;  LR+,  6.44;  and
R-,  0.37.
For  comparative  purposes,  values  corresponding
o  the  APACHE-II  and  Ranson  scores  were  obtained.
ue  to  the  change  of  the  classiﬁcation  system,  it  was
ecessary  to  do  the  ROC  curve  analysis  and  contingency
ables  to  determine  the  maximum  cut-off  points  for  these
 diagnostic  scales.  The  cut-off  points  coincided  with  those
16  A.A.  Gutiérrez-Jiménez  et  al.
Table  1  General  characteristics  of  the  patients  with  acute  pancreatitis.
Variable  Total
population
(n  =  96)
Mild  acute
pancreatitis
(n  =  70)
Moderately  severe
acute  pancreatitis
(n  =  17)
Severe  acute
pancreatitis
(n =  9)
P
Age  in  years  40.05  ±  13.80  39.45  ±  14.51  41.58  ±  13.28  41.78  ±  9.01  0.79a
(range)  (18-74)  (18-74)  (21-71)  (25-57)
BMI (mean)  28.9  ±  5.58  27.9  ±  5.28  33.32  ±  5.56  28.24  ±  4.08  0.006a
Sex
Men  37  (38.5%)  23  9  5  0.170c
Women 59  (61.5%) 47  8  4
Etiology
Biliary 67  (69.8%) 58  6  3  0.000c
Alcoholic  12  (12.5%)  4  5  3
Idiopathic 11  (11.5%)  4  6  1
HTG 5  (5.2%)  3  0  2
Drug-related  1  (1%)  1  0  0
Comorbidities
None 63  (65.6%) 51  10  2  0.009c
One  or  more 33  (34.4%) 19  7  7
Time of  admission  after  symptom  onset
0 to  24  h  33  (34.4%)  22  6  5  0.415c
25  to  48  h  34  (35.4%)  24  8  2
49 to  72  h  29  (30.2%)  24  3  2
Days of  hospital  stay  11.17  ±  10.42  7.9  ±  2.71  20.64  ±  17.4  18.14  ±  16.29  0.000b
Source: Direct.
a One-way ANOVA.
b Kruskal-Wallis test.
c Chi-square test.
Table  2  Complications  that  presented  in  patients  with  moderately  severe  and  severe  acute  pancreatitis.
Severity  Persistent
organ  failure
Transitory
organ  failure
Local
complication
Systemic
complication
Death
Severe  (n  =  9)  9  (100%)  0  (0%)  3  (33.3%)  3  (33.3%)  2  (22.2%)
Moderately 0  (0%)  10  (58.8%)  11  (64.7%)  0  (0%)  1  (5.8%)
r
c
s
d
msevere (n  =  17)
Source: Direct.
eported  in  the  literature  before  the  classiﬁcation  system
hange,6,9,10,12 and  they  were:  Ranson’s  score  3,  APACHE-II
core  8  (ﬁg.  2).
The  values  obtained  for  these  prognostic  criteria  are
etailed  in  Table  4.  It  is  worth  noting  that  when  the
c
h
s
s
Table  3  Mean  values  of  the  prognostic  severity  factors  in  acute  p
Factor  Total
population
(n  =  96)
Mild  acute
pancreatitis
(n  =  70)
Total  serum  calcium  (mg/dl)  8.17  ±  1.23  8.52  ±  0.98  
Corrected  calcium  (mg/dl)  8.23  ±  0.95  8.44  ±  0.77  
Ranson’s  at  48  h  2.32  ±  1.39  1.81  ±  1.3  
APACHE-II  upon  admission  4.92  ±  5.11  3.33  ±  2.81  
Source: Direct.
a One-way ANOVA.
b Kruskal-Wallis test.aximum  cut-off  points  (highlighted  in  black)  are  taken  into
onsideration,  the  ACC  predictive  value  at  7.5  mg/dl  is  the
ighest  of  the  4  criteria,  and  the  TC  predictive  value  is  very
imilar  to  the  Ranson  and  APACHE-II  scores.  This  table  also
hows  the  values  corresponding  to  the  sub-maximum  cut-off
ancreatitis.
Moderately  severe
acute  pancreatitis
(n  =  17)
Severe  acute
pancreatitis
(n =  9)
p
7.55  ±  1.04  6.64  ±  1.71  0.000a
7.89  ±  0.74  7.16  ±  1.59  0.000a
3.24  ±  1.15  4.1  ±  1.05  0.000b
7.05  ±  4.69  12.33  ±  9.74  0.000b
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Figure  1  ROC  curves  of  the  TC  values  (total  serum  calcium)  and  ACC  (albumin-corrected  calcium)  in  the  ﬁrst  24  h  from  hospital
admission for  predicting  severe  AP.  The  maximum  cut-off  point  for  both  is  7.5  mg/dl.  The  area  under  the  curve  (AUC)  for  TC  (light
grey) is  0.775  (95%CI,  0.565-0.985);  the  AUC  for  ACC  (dark  grey)  is  0.753  (95%CI,  0.530-0.975).
Origin of the curve
ROC Curve
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Figure  2  ROC  curves  of  the  APACHE-II  score  values  upon  admission  and  the  Ranson’s  score  value  at  48  h  for  predicting  severe  AP.
The maximum  cut-off  points  are  8  for  the  APACHE-II  score  and  3  for  t
score (light  grey)  is  0.773  (95%CI,  0.585-0.961);  the  AUC  for  the  Ranhe  Ranson’s  score.  The  area  under  the  curve  for  the  APACHE-II
son’s  score  (dark  grey)  is  0.872  (95%CI,  0.760-0.985).
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Table  4  Sensitivity,  speciﬁcity,  predictive  values,  and  likelihood  ratios  of  the  factors  analyzed  for  predicting  progression  to
severe acute  pancreatitis.
Factor  S  (%)  Sp  (%)  PPV  (%)  NPV  (%)  LR+  LR−
APACHE-II  upon  admission  (cut-off
point  ≥  8)a
67  87  35  96  1.67  0.41
APACHE-II upon  admission  (cut-off
point  ≥  12)
55  94  50  95  9.11  0.47
Ranson’s at  48  h
(cut-off  point  ≥  3)a
89  67  23  98  2.66  0.16
Ranson’s at  48  h
(cut-off  point  ≥  5)
44  96  57  94  12  0.57
Total serum  calcium
(≤ 7.5  mg/dl)a
67  82  27  96  3.62 0.41
Total serum  calcium
(≤ 6.5  mg/dl)
56  95  56  95  12.1  0.46
Corrected calcium
(≤  7.5  mg/dl)a
67  90  40  96  6.44  0.37
Corrected calcium
(≤  6.5  mg/dl)
56  99  83  95  48.3  0.44
S: sensitivity; Sp: speciﬁcity; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative
likelihood ratio.
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a Optimum cut-off points.
oints  (stricter,  not  highlighted)  for  each  criterion.  When  the
ample  patients  had  TC  and  ACC  values  under  the  maximum
ut-off  point  (7.5  mg/dl),  the  relative  risk  for  developing
evere  AP  rose  signiﬁcantly.  The  OR  for  TC  was  8.87  (95%CI:
 -  39.3;  p  =  0.002);  and  for  ACC  was  17.33  (95%CI:  3.69  -
1.5;  p  < 0.000).
alcium  levels  and  Ranson  and  APACHE-II  scores  as
evere and  moderately  severe  acute  pancreatitis
redictors
he  fact  that  the  deﬁnitive  diagnosis  of  AP  severity  depends
n  the  duration  of  associated  organ  failure  complicates  mak-
ng  an  early  prediction  of  whether  the  patients  will  ﬁnally
resent  with  severe  or  moderately  severe  AP.  Our  approach
o  the  problem  was  to  put  the  patients  with  moderately
evere  AP  and  severe  AP  together  in  one  group.  In  this
anner,  we  had  a  group  of  26  patients  that  was  utilized
o  determine  the  maximum  cut-off  points  for  this  condition
nd  for  the  4  prognostic  factors  through  contingency  tables.
n  the  end,  each  cut-off  point  was  analyzed  through  OR  to
etermine  the  relative  risk  for  presenting  with  severe  AP
nd  moderately  severe  AP,  separately.
The  results  of  this  procedure  are  shown  in  Tables  5  and  6.
able  5  displays  the  maximum  cut-off  points  for  predicting
hether  the  patient  will  present  with  severe  or  moderately
evere  AP,  without  excluding  either  possibility.  In  addition,
he  cut-off  points  in  which  the  patient  has  a  greater  risk  for
rogressing  to  severe  AP  are  included.  Table  6  details  the
elative  risk  for  progressing  to  severe  or  moderately  severe
P  for  both  cut-off  points  and  for  each  criterion.  It  is  striking
hat  the  highest  cut-off  point  for  the  APACHE-II  and  Ranson
cores  and  the  lowest  for  TC  and  ACC  are  associated  with
i
t
s
r greater  risk  for  having  severe  AP.  The  other  cut-off  point
resents  the  opposite  situation.
iscussion
ur  study  results  suggest  that  in  patients  with  AP  that  are
dmitted  within  72  h  of  symptom  onset,  both  TC  and  ACC
ithin  the  ﬁrst  24  h  of  admission  (cut-off  point  7.5  mg/dl)
re  adequate  predictors  of  AP  severity.  With  the  7.5  mg/dl
ut-off  point,  the  S  and  Sp  of  the  TC  are  very  similar  to
hose  of  the  APACHE-II  score  and  the  PPV  of  the  ACC  is  the
ighest  of  the  4  criteria  analyzed.
Reliable  identiﬁcation  of  patients  with  early  stage  severe
P  is  complicated,32 and  despite  the  fact  that  the  Ranson
nd  APACHE-II  scores  are  widely  used,  they  have  negative
spects  that  complicate  their  use  and  interpretation  as  pro-
nostic  severity  tests.  Decision-making  based  on  diagnostic
ests  requires  adequate  interpretation  of  the  results  and
nowledge  of  their  properties,  mainly  S,  Sp,  predictive  val-
es,  and  likelihood  ratios. 33,34 In  our  study,  we  found  that
he  Ranson’s  score  was  highly  sensitive,  but  its  Sp  was  regu-
ar,  and  its  PPV  was  poor;  especially  when  using  the  new  AP
lassiﬁcation  criteria.  The  PPV  of  the  Ranson’s  score  indi-
ated  that  its  application  produces  a  large  number  of  false
ositives.  These  characteristics  of  the  Ranson’s  score  coin-
ide  with  those  reported  in  other  studies  that  suggest  that
t  cannot  be  regarded  as  an  adequate  prognostic  scale. 35
evertheless,  due  to  its  elevated  S,  it  can  be  a  very  good
creening  test.  Another  important  limitation  of  the  Ranson’s
core  is  that  for  its  complete  evaluation,  data  need  to  be
ollected  up  to  48  h  from  the  time  of  admission.  This  results
n  a  signiﬁcant  delay  for  the  patients  with  severe  AP,  given
hat  during  this  period  of  time,  ﬂuid  resuscitation  or  the
earch  for  spaces  for  intensive  care  management  can  be  car-
ied  out.  At  any  rate,  the  new  version  of  the  Atlanta  criteria
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Table  5  Sensitivity  and  speciﬁcity  values,  predictive  values,  and  likelihood  ratios  of  the  factors  analyzed  for  predicting  the
progression of  acute  pancreatitis  to  a  grade  of  severity.
Factor  S  (%)  Sp  (%)  PPV  (%)  NPV  (%)  LR+  LR−
APACHE-II  upon  admission  (cut-off
point  ≥  5)
69  69  47  85  2  0.37
APACHE-II upon  admission  (cut-off
point  ≥  7)
54  88  64  83  4.38  0.53
Ranson’s at  48  h
(cut-off  point  ≥  1)
100  13  32  100  1.14  0
Ranson’s at  48  h
(cut-off  point  ≥  2)
92  37  37  92  1.47  0.2
Total serum  calcium
(≤ 8.5  mg/dl)
81  53  39  88  1.71 0.36
Total serum  calcium
(≤ 8  mg/dl)
73  73  50  88  2.43  0.38
Corrected calcium
(≤  8.3  mg/dl)
73  63  42  86  1.96  0.42
Corrected calcium
(≤  7.9  mg/dl)
58  76  47  82  2.4  0.56
S: sensitivity; Sp: speciﬁcity; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative
i
v
t
t
blikelihood ratio.
Source: Direct.
suggests  that  patients  with  moderately  severe  AP  and  severe
AP  can  be  treated  in  the  same  way  until  a  precise  classiﬁ-
cation  is  possible,30 and  with  the  Ranson’s  score  as  the  only
criterion,  it  is  not  possible  to  make  any  prediction  before
48  h.The  APACHE-II  score  is  less  sensitive  than  the  Ranson’s
score,  but  in  relation  to  the  maximum  cut-off  points,
it  is  more  speciﬁc  and  it  has  a  higher  PPV.  Therefore,
m
s
h
Table  6  Relative  risk  associated  with  levels  of  total  calcium,  corr
factors of  moderately  severe  and  severe  acute  pancreatitis.
Factor  Moderately  se
pancreatitis
OR  (95%CI)
APACHE-II  upon  admission
(cut-off  point  ≥  5)
4.43  (1.41  --  1
APACHE-II  upon  admission
(cut-off  point  ≥  7)
3  (0.971  --  
Ranson’s at  48  h
(cut-off  point  ≥  1)
1.26  (1.13  --  1
Ranson’s at  48  h
(cut-off  point  ≥  2)
3.67  (0.77  --  1
Total serum  calcium
(≤ 8.5  mg/dl)
4.55  (1.21  --  1
Total  serum  calcium
(≤ 8  mg/dl)
4.89  (1.56  --  1
Corrected calcium
(≤  8.3  mg/dl)
4.77  (1.42  --  1
Corrected  calcium
(≤  7.9  mg/dl)
2.3  (0.78  --  6
CI: Conﬁdence interval; OR: odds ratio.
Source: Direct.
a Nonsigniﬁcant OR (p > 0.05, chi-square test).t  has  a lower  proportion  of  false  positives  when  the
alues  surpass  the  cut-off  point.35,36 These  properties,
hat  have  been  determined  in  numerous  studies  prior  to
he  Atlanta  Classiﬁcation  revision,6,9,10,12 were  conﬁrmed
y  the  measurements  obtained  in  our  study  (Table  4),
aking  it  a  particularly  useful  test  upon  patient  admis-
ion  and  a  marker  of  improvement  or  worsening  in  later
ours.
ected  calcium,  and  Ranson  and  APACHE-II  scores  as  prognostic
vere  acute Severe  acute  pancreatitis
OR (95%CI)
3.95)  3.12  (0.73  --  13.4)a
9.26)a 8.93  (2.004  --  39.8)
.41)  1.12  (1.04  --  1.21)
 7.38)a 1.16  (1.054  --  1.28)
7.1)  2.97  (0.58  --  15.15)a
5.35)  6.32  (1.24  --  32.3)
5.9)  2.46  (0.58  --  10.5)a
.73)a 5.25  (1.22  --  22.7)
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The  most  important  limitation  in  using  the  APACHE-II
core  is  that  its  calculation  is  complex  and  requires  equip-
ent  that  may  not  be  available  at  the  majority  of  medical
nits.  Furthermore,  it  must  be  noted  that  when  stricter  cut-
ff  points  are  considered,  some  of  the  advantages  of  the
cale  are  lost,  at  least  when  the  new  AP  classiﬁcation  is
sed  (compare  the  sub-maximum  cutoff  points  in  Table  4).
With  respect  to  the  TC  and  ACC,  in  our  study  we  found
hat  the  Sp  and  S  values  for  TC  with  a  cut-off  point  of
.5  mg/dl  were  very  similar  to  those  of  the  APACHE-II  score,
nd  its  Sp  was  superior  to  that  of  the  Ranson’s  score.
 TC  concentration  lower  than  7.5  mg/dl  would  be  enough
o  identify  patients  with  severe  AP  as  adequately  as  with  the
PACHE-II  score.  But  if  the  TC  value  were  to  go  under  the
econd  cut-off  point  (6.5  mg/dl),  the  Sp  values,  predictive
alues,  and  likelihood  ratios  would  surpass  those  of  the  2
iagnostic  scales  (Table  4).  In  other  words,  when  there  was
 TC  concentration  below  6.5  mg/dl,  the  patients  had  a  60%
robability  of  presenting  with  severe  AP.  This  predictive
alue  is  even  superior  to  that  of  the  APACHE-II  score,  and
hows  us  the  necessity  of  understanding  TC  properties  as  a
rognostic  factor  of  AP  severity.  A  calcium  level  between
he  2  cut-off  points  (between  7.5  and  6.5  mg/dl)  will  detect
atients  with  severe  pancreatitis  as  well  as  the  APACHE-II
oes,  but  its  capacity  to  adequately  predict  patient  pro-
ression  will  be  inferior.  When  the  TC  value  goes  below
.5  mg/dl,  the  predictive  value  will  be  56%  and  diagnos-
ic  accuracy  approximately  60%  (calculated  with  the  Fagan
omogram  method  and  an  estimated  AP  prevalence  of  9.4%),
hich  is  superior  to  that  of  the  Ranson  and  APACHE-II  scores.
herefore,  it  is  necessary  to  have  the  2  TC  cut-off  points  in
ind  when  making  the  diagnosis  and  prognosis  of  patients
ith  AP.  As  a  practical  example  of  the  above-stated,  in  our
tudy  there  were  2  patients  that  did  not  meet  the  cut-off
oint  for  detecting  severity  with  the  APACHE-II  score  upon
dmission;  they  had  a  TC  under  7.5  mg/dl,  and  they  later
eveloped  severe  AP.
In  regard  to  ACC,  with  the  7.5  mg/dl  cut-off  point,  its  S
as  the  same  as  that  of  the  rest  of  the  criteria  analyzed,  but
ts  PPV  and  LR+  were  the  highest.  With  the  6.5  mg/dl  cut-off
oint,  its  PPV  reached  83%  and  its  diagnostic  accuracy  was
pproximately  82%  (calculated  with  the  Fagan  nomogram
ethod  and  an  estimated  AP  prevalence  of  9.4%).  These
igh  prediction  levels  and  the  ease  in  calculating  them  when
he  serum  albumin  level  is  known,  make  obtaining  the  ACC
oncentration  worthwhile,  since  it  considerably  increases
iagnostic  accuracy.
The  repercussions  of  using  the  revised  Atlanta  Classiﬁca-
ion  on  the  results  of  our  study  merit  further  comment.  First
f  all,  it  brought  about  a  decrease  in  cases  labeled  as  severe
P,  lowering  the  approximately  20%  prevalence  that  was
eported  in  studies  based  on  the  previous  literature,5--8,10
o  only  9.4%.  This  situation  has  an  immediate  impact  on
he  properties  of  diagnostic  tests  and  criteria,  because  it
s  well  known  that  although  S  and  Sp  are  independent  from
revalence,  predictive  values  and  likelihood  ratios  are  not.
ven  the  most  sensitive  and  speciﬁc  diagnostic  tests  give
 great  number  of  false  positives  when  they  are  used  for
iagnosing  low  prevalence  diseases.34,37 Because  the  new
lassiﬁcation  is  recent,  we  have  not  found  any  references
n  severe  AP  prevalence  using  the  new  criteria.  But  if  the
revalence  rates  are  similar,  a  decrease  in  the  predictive
F
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haracteristics  of  the  tests  similar  to  that  observed  in  our
tudy  can  be  expected.
On  the  other  hand,  the  fact  that  the  new  classiﬁcation  no
onger  refers  to  a  dichotomy,  but  rather  to  a  severity  con-
inuum  of  the  disease,  the  conventional  interpretation  of
iagnostic  test  results  meets  with  complications.  In  princi-
al,  it  is  possible  to  opt  for  2  solutions:  to  continue  using  the
esults  in  terms  of  severity  and  forgetting  about  the  uncer-
ain  area  that  the  term  ‘moderately  severe  AP’  suggests,  or
o  treat  moderately  severe  AP  as  if  it  were  severe  AP,  just
s  the  international  consensus  that  proposed  the  new  classi-
cation  does.30 But  it  is  advisable  to  remember  that  severe
P  is  associated  with  higher  mortality  and  complication  rates
hat  require  different  treatment  alternatives,30 which  is  why
e  feel  it  is  useful  to  manage  the  diagnostic  tests  precisely
s  a  continuum.  For  example,  we  can  see  in  Tables  4--6  as  a
hole,  the  maximum  cut-off  point  for  detecting  severe  AP
ith  the  APACHE-II  scale  is  8,  but  that  the  cut-off  points  5
nd  7  give  us  relevant  information  on  the  possibility  of  the
atient  presenting  with  moderately  severe  AP  that  does  not
rogress  to  the  severe  status.  The  cut-off  point  of  5  enables
ore  patients  to  be  identiﬁed,  but  with  a  higher  number  of
alse  positives  and  a  greater  probability  of  their  ﬁnally  pre-
enting  with  moderately  severe  AP  (OR  =  4.43).  In  contrast,
he  cut-off  point  of  7  has  less  S,  but  the  patients  at  this
evel  have  a  greater  probability  of  progressing  to  severe  AP
OR  =  8.93).  The  other  prognostic  criteria  analyzed  had  very
imilar  behavior,  and  this  was  especially  notorious  in  the
ase  of  ACC.  If  these  characteristics  are  conﬁrmed  in  later
tudies,  the  tests  will  give  us,  more  than  the  probability  of
 diagnosis,  the  probability  that  the  patient  will  progress
o  a  certain  severity  of  AP.  This  knowledge  will  allow  the
ttending  physician  to  anticipate  the  therapeutic  measures
nd  additional  studies  necessary  if  the  patient  progresses  to
tatuses  of  greater  severity.
And  ﬁnally,  we  wish  to  point  out  that  a  large  number  of
ospital  care  centers  have  access  to  TC  and  ACC  use,  but  not
s  many  have  access  to  the  resources  required  for  using  the
PACHE-II  scale  and  other  AP  severity  markers,  such  as  C-
eactive  protein,  interleukin  6,  TMX,  or  procalcitonin. 6,12--14
erum  calcium  and  albumin  for  calculating  ACC  are  simple
iochemical  markers  that  are  routinely  determined  in  the
ajority  of  hospital  centers.  Their  use  as  prognostic  factors
f  severity  in  AP  would  be  valuable  for  identifying  those
ersons  that  require  intensive  care,  even  at  the  primary  and
econdary  care  center  levels.
onclusions
erum  calcium  and  ACC  obtained  within  the  ﬁrst  24  h  of  hos-
ital  admission  are  useful  predictors  of  severity  in  AP  and
ave  S,  Sp,  and  predictive  values  that  are  comparable  with
hose  of  the  traditional  prognostic  scales.  With  an  adequate
nterpretation  of  their  cut-off  points,  they  are  valuable  for
dentifying  the  patients  that  require  intensive  care  support,
ven  in  primary  and  secondary  care  centers.inancial disclosure
o  ﬁnancial  support  was  received  in  relation  to  this  article.
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